Ascendia Pharmaceuticals, a specialty pharmaceutical company engaged in nano-formulation design, formulation, and manufacture of poorly soluble molecules, today announced that it has entered into a collaboration with KC Pharmaceuticals for the development of five over-the-counter (OTC) sterile ophthalmic drop medicines.    KC Pharmaceuticals will leverage Ascendia’s formulation development and analytical testing capabilities to develop these new products. KC Pharmaceuticals will leverage...